江西阳光乳业股份有限公司 关于 2024 年度利润分配预案的公告 一、 审议程序 江西阳光乳业股份有限公司（以下简称"公司"）于 2025 年 4 月 16 日召开 第六届董事会第六次会议，以 7 票同意、0 票反对、0 票弃权、0 票回避审议通 过了《关于 2024 年度利润分配预案的议案》，尚需提交 2024 年度股东大会审议。 二、利润分配的基本情况 证券代码：001318 证券简称：阳光乳业 公告编号：2025-005 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 | 项目 | 本年度 | 上年度 | 上上年度 | | --- | --- | --- | --- | | 现金分红总额（元） | 50,878,800 | 45,225,600 | 42,399,000 | | 回购注销总额（元） | 0 | 0 | 0 | | 归属于上市公司股东的净利 | 114,564,893.06 | 115,823,647.33 | 110,889,403.79 | | 润（元） | | | | | 合并报表本年度末累计未分 | | 433,930,717.91 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥104,943,144.28, a decrease of 3.62% compared to ¥108,881,781.06 in the same period last year[5] - Net profit attributable to shareholders was ¥22,059,641.87, representing an increase of 2.58% from ¥21,504,922.08 year-on-year[5] - Basic earnings per share for Q1 2025 were ¥0.0780, up 2.50% from ¥0.0761 in the same period last year[5] - Net profit for the current period increased by 9.2% to ¥21,502,375.38 compared to ¥19,689,324.27 in the previous period[18] - Earnings per share (EPS) for the current period was ¥0.0780, up from ¥0.0761 in the previous period[18] Cash Flow and Liquidity - The net cash flow from operating activities increased by 458.28%, reaching ¥20,993,336.25, compared to a negative cash flow of ¥5,859,400.09 in the previous year[9] - The net cash flow from operating activities was $20,993,336.25, a significant improvement from a negative cash flow of $5,859,400.09 in the previous period, indicating a recovery in operational efficiency[20] - The net cash flow from investment activities was $8,141,348.87, recovering from a negative cash flow of $4,680,728.28 previously, showcasing effective asset management[20] - The net increase in cash and cash equivalents for the period was $29,134,685.12, contrasting with a decrease of $10,540,128.37 in the previous period, indicating improved liquidity[21] - The ending balance of cash and cash equivalents reached $581,678,770.07, up from $477,347,078.17 at the end of the previous period, reflecting a stronger cash position[21] Assets and Equity - Total assets at the end of the reporting period were ¥1,501,614,360.67, reflecting a growth of 0.85% from ¥1,488,952,832.62 at the end of the previous year[5] - Shareholders' equity attributable to the parent company increased by 1.57% to ¥1,427,511,641.43 from ¥1,405,451,999.56[5] - Total assets increased to ¥1,501,614,360.67 from ¥1,488,952,832.62, reflecting a growth of 0.9%[15] - Total equity attributable to shareholders increased to ¥1,427,511,641.43 from ¥1,405,451,999.56, marking a growth of 1.6%[15] Costs and Expenses - Total operating costs decreased by 6.0% to ¥82,148,198.66 from ¥87,235,482.44, with operating costs specifically down by 4.2% to ¥67,586,957.14[17] - Research and development expenses decreased significantly by 37.9% to ¥3,166,228.24 from ¥5,096,005.31[17] - Cash paid for purchasing goods and services decreased to $51,618,125.65 from $77,319,695.23, suggesting improved cost management[20] Other Financial Aspects - The company reported a loss of ¥744,008.99 from the disposal of non-current assets, primarily due to losses from biological assets[7] - Government subsidies recognized in the current period amounted to ¥741,003.18, contributing positively to the financial results[7] - The company has strengthened its management of procurement payments, which significantly improved cash flow from operations[9] - The first quarter report was not audited, which may affect the perception of financial reliability[22] - The cash flow statement for the current period is yet to be detailed, indicating potential areas for further analysis[19] - The total number of ordinary shareholders at the end of the reporting period was 23,892[11] - The company reported a credit impairment loss of ¥581.81, contrasting with a gain of ¥24,320.34 in the previous period[18] - Cash received from sales of goods and services was $120,093,669.14, slightly up from $119,958,994.41, indicating stable revenue generation[20] - Cash received from tax refunds increased to $1,607.85 from $148.16, indicating better tax recovery processes[20] - The company did not report any cash inflows from financing activities, indicating a focus on internal funding sources[21]

Dividend Distribution - The company plans to distribute a cash dividend of 1.8 yuan per 10 shares to all shareholders, based on a total of 282,660,000 shares[4]. - The cash dividend amount is subject to adjustment if there are changes in total share capital before the equity distribution registration date[197]. - The cash dividend distribution is based on a total share capital of 28,266,000 shares[197]. - The total distributable profit for 2024 is 433,930,717.91 yuan, with the cash dividend amounting to 100% of the profit distribution total[195]. - The company reported a net profit of 114,564,893.06 yuan for 2024 after accounting for statutory surplus reserves[196]. - The remaining undistributed profits will be carried forward to future periods, with no stock dividends or capital reserve increases planned[197]. - The company has not made any adjustments to its profit distribution policy during the reporting period, ensuring compliance with regulations[193]. Financial Performance - The company's operating revenue for 2024 was ¥519,418,156.94, a decrease of 8.86% compared to ¥569,933,839.82 in 2023[24]. - The net profit attributable to shareholders for 2024 was ¥114,564,893.06, down 1.09% from ¥115,823,647.33 in 2023[24]. - The net profit after deducting non-recurring gains and losses increased by 2.88% to ¥119,567,796.33 in 2024 from ¥116,224,472.31 in 2023[24]. - The net cash flow from operating activities decreased by 17.23% to ¥139,542,716.05 in 2024 from ¥168,586,511.39 in 2023[24]. - Total assets at the end of 2024 were ¥1,488,952,832.62, reflecting a 4.31% increase from ¥1,427,404,152.93 at the end of 2023[24]. - The net assets attributable to shareholders increased by 5.19% to ¥1,405,451,999.56 at the end of 2024 from ¥1,336,112,706.50 at the end of 2023[24]. - The company's revenue for 2024 was CNY 519,418,156.94, a decrease of 8.87% compared to CNY 569,933,839.82 in 2023[64]. - The distribution model accounted for 82.63% of total revenue in 2024, generating CNY 429,210,128.76, down 10.97% from the previous year[64]. - Direct sales revenue increased by 2.68% to CNY 90,208,028.18, representing 17.37% of total revenue in 2024[64]. Market and Industry Outlook - In 2024, China's dairy industry is facing overall pressure, with national milk production expected to decline by 2.8% year-on-year, and large-scale dairy farms reducing their cattle inventory by 200,000 to 300,000 heads[35]. - The average per capita dairy consumption in China is approximately one-third of the world average and about half of that in developing countries, indicating significant future growth potential[35]. - According to the "Chinese Dietary Guidelines (2022)", the recommended daily intake of dairy products has increased to 300-500 grams, encouraging higher consumption levels[40]. - The dairy industry is focusing on quality improvement through advanced production technologies and strict quality management systems, enhancing consumer confidence and international competitiveness[36]. - The government is promoting dairy consumption through policies like the "Healthy China 2030" plan and the "National Nutrition Plan (2017-2030)", aiming to enhance the dairy industry's development[41]. - The overall growth rate of the Chinese dairy industry is expected to slow down significantly in 2024, with potential negative growth in the following years due to demographic changes and consumption diversification[134]. - Despite short-term challenges, the long-term outlook for the dairy industry remains positive, driven by low per capita dairy consumption compared to global averages[134]. Product Development and Innovation - The company launched new products including A2-β casein concentrated milk and "Old Nanchang" osmanthus wine yogurt, which received positive consumer feedback[63]. - The company is developing a new high-protein, high-calcium yogurt using nanofiltration technology, which is expected to expand the consumer base and increase product variety[110]. - The company has completed the development of a new black sugar ginger soup, which is now in production and aims to become a mainstream product[112]. - The company plans to invest in the research and development of at least 10 new products and projects for 2025, with a target of launching no less than 15 new products and phasing out at least 10 old products, allocating over 3% of revenue to R&D expenses[137]. Operational Efficiency and Cost Management - The company's main business cost for 2024 is approximately ¥322.79 million, accounting for 99.99% of total operating costs, a decrease from ¥362.71 million in 2023[79]. - The average purchase price of whole milk powder decreased by 30.73% in 2024, resulting in a cost reduction of approximately ¥4.86 million[70]. - The company's operating costs decreased by 11.00% to ¥322,804,211.96, attributed to a decline in raw material procurement prices[90]. - The gross profit margin for product sales reached 38%, an increase of 1.5 percentage points compared to 2023, despite a decline in overall revenue[92]. - The company has established a comprehensive sales network, including home delivery, supermarkets, and specialty stores, enhancing customer loyalty and repeat purchase rates[81]. - The cold chain logistics system developed by the company ensures product quality and timely delivery, crucial for maintaining consumer trust in low-temperature products[82]. Risk Management and Compliance - The company is facing risks related to insufficient milk supply and price fluctuations, with measures in place to increase self-supply and establish long-term contracts with suppliers to mitigate these risks[148]. - The fundraising investment project is expected to significantly increase fixed assets and production capacity, but there are risks of not meeting expected returns due to market changes or management issues, which could lead to a substantial decline in net profit[149]. - Changes in tax policies could adversely affect the company's performance, but the company aims to enhance core competitiveness and optimize product structure to mitigate these impacts[151]. - The company has established a robust internal control system to mitigate operational risks, focusing on areas such as food safety and financial management[144]. - The company has received a standard unqualified opinion from the auditor regarding internal controls, ensuring compliance with relevant laws and regulations[199]. Governance and Management - The company maintains an independent human resources management system, with senior management not holding positions in the controlling shareholder's other enterprises[164]. - The company has established an independent financial department with a standardized accounting system, ensuring independent financial decision-making[167]. - The board of directors and senior management have been in their positions since December 16, 2020, with terms ending on December 18, 2026[171]. - The company has a total of 12 directors and supervisors, with a diverse range of expertise in various fields[182]. - The company has a structured remuneration decision-making process that involves proposals from independent directors and approval from the board and shareholders[180]. - The company has a commitment to transparency in its remuneration practices, adhering to its established compensation policies[180]. Employee and Community Engagement - The total number of employees at the end of the reporting period is 1,011, with 714 in the parent company and 297 in major subsidiaries[189]. - The company has established a comprehensive employee training system to enhance the overall quality and capabilities of its workforce[192]. - The company actively promoted its brand, hosting over 200 community events and participating in more than 10 major exhibitions throughout the year[94]. - The company has 57 retired employees for whom it bears costs[189].

东兴证券股份有限公司 关于江西阳光乳业股份有限公司 2024 年度内部控制自我评价报告的核查意见 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为江西阳光 乳业股份有限公司（以下简称"阳光乳业"或"公司"）首次公开发行股票并上 市的保荐机构及持续督导机构，根据《证券发行上市保荐业务管理办法》《深圳 证券交易所股票上市规则》《企业内部控制基本规范》《深圳证券交易所上市公 司自律监管指引第 1 号——主板上市公司规范运作》《深圳证券交易所上市公司 自律监管指引第 13 号——保荐业务》等相关法律、法规和规范性文件的规定， 对阳光乳业 2024 年度内部控制自我评价报告进行了核查，并发表如下意见： 一、保荐机构的核查工作 1.建立和完善符合现代管理要求的内部组织架构，形成科学的决策机制、执 行机制和监督机制，保证公司经营管理目标的实现； 2.建立切实有效的风险控制系统，强化风险管理，保证公司业务活动的健康 运转； 3.避免或降低风险，消除隐患，防止并及时发现和纠正各种错误行为，保护 公司财产的安全完整； 东兴证券通过查阅公司各项业务和管理规章制度、相关股东大会、董事会等 会议记录、监事会报告、审计报告 ...

江西阳光乳业股份有限公司 募集资金存放与实际使用情况 审核报告 大信专审字[2025]第 6-00006 号 大信会计师事务所（特殊普通合伙） WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 大信会计师事务所 北京市海淀区知春路 1 号 学院国际大厦 22 层 2206 邮编 100083 WUYIGE Certified Public Accountants.LLP Room 2206 22/F, Xueyuan International Tower No.1 Zhichun Road, Haidian Dist. Beijing, China, 100083 电话 Telephone：+86（10）82330558 传真 Fax： +86（10）82327668 网址 Internet： www.daxincpa.com.cn 募集资金存放与实际使用情况审核报告 大信专审字[2025]第 6-00006 号 江西阳光乳业股份有限公司全体股东： 我们接受委托，对后附的江西阳光乳业股份有限公司（以下简称"贵公司"）《2024年 度募集资金存放与实际使用情况的专项报告》（以下 ...

江西阳光乳业股份有限公司 审 计 报 告 大信审字[2025]第 6-00018 号 大信会计师事务所（特殊普通合伙） WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 大信会计师事务所 北京市海淀区知春路 1 号 学院国际大厦 22 层 2206 邮编 100083 WUYIGE Certified Public Accountants.LLP Room 2206 22/F,Xueyuan International Tower No.1 Zhichun Road,Haidian Dist. Beijing,China,100083 电话 Telephone：+86（10）82330558 传真 Fax： +86（10）82327668 网址 Internet： www.daxincpa.com.cn 审计报告 大信审字[2025]第 6-00018 号 江西阳光乳业股份有限公司全体股东： 一、审计意见 我们审计了江西阳光乳业股份有限公司（以下简称"贵公司"）的财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母公司利润表、合并及 ...

关于江西阳光乳业股份有限公司 变更部分募集资金用途及募集资金项目延期的核查意见 东兴证券股份有限公司 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为江西阳光乳 业股份有限公司（以下简称"阳光乳业"或"公司"）首次公开发行股票并上市的 保荐机构及持续督导机构，根据《上市公司监管指引第 2 号——上市公司募集资金 管理和使用的监管要求》《证券发行上市保荐业务管理办法》《深圳证券交易所股 票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规 范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等相关 法律、法规和规范性文件的规定，对阳光乳业关于变更部分募集资金用途及募集资 金项目延期事项进行了审慎的核查，核查情况如下： 一、变更募集资金投资项目的概述 （一）募集资金基本情况 经中国证券监督管理委员会《关于核准江西阳光乳业股份有限公司首次公开发 行股票的批复》（证监许可（2022）649 号）核准，江西阳光乳业股份有限公司（以 下简称：公司）于 2022 年 5 月于深圳证券交易所向社会公众公开发行人民币普通 股(A 股)7,070 万股，发行价为 9.46 ...

东兴证券股份有限公司 关于江西阳光乳业股份有限公司 关于 2024 年度募集资金存放与使用情况的专项报告的 核查意见 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为江西阳 光乳业股份有限公司（以下简称"阳光乳业"或"公司"）首次公开发行股票并上 市的保荐机构及持续督导机构，根据《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求》《证券发行上市保荐业务管理办法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公 司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等 相关法律、法规和规范性文件的规定，对阳光乳业 2024 年度募集资金存放与使用 情况进行了核查，并发表如下意见： 一、募集资金基本情况 （一）扣除发行费用后的实际募集资金金额、资金到账时间 经中国证券监督管理委员会《关于核准江西阳光乳业股份有限公司首次公开发 行股票的批复》（证监许可（2022）649 号）核准，公司 2022 年 5 月于深圳证券交 易所向社会公众公开发行人民币普通股（A 股）7,070 万股，发行价为 9.46 元/股， 募集资金 ...

东兴证券股份有限公司 关于江西阳光乳业股份有限公司 使用暂时闲置募集资金进行现金管理的核查意见 江西阳光乳业股份有限公司（以下简称"阳光乳业"或"公司"） 于 2025 年 4 月 16 日召开的第六届董事会第六次会议审议通过了《关于使用暂时闲置募集资 金进行现金管理的议案》，同意在确保不影响募集资金投资项目建设、募集资金 使用的情况下，使用不超过人民币 4.5 亿元的暂时闲置募集资金进行现金管理， 单笔现金管理的产品期限最长不超过一年，在上述额度内，进行现金管理的资金 可以滚动使用。 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为阳光乳业 保荐机构及持续督导机构，根据《证券发行上市保荐业务管理办法》《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板 上市公司规范运作》等相关法律、法规和规范性文件的规定，对阳光乳业本次使 用部分暂时闲置募集资金进行现金管理的事项进行了专项核查，并发表如下意见： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准江西阳光乳业股份有限公司首次公开 发行股票的批复》（证监许可〔2022〕649 号）的核准，公司公开发行人民币 ...

东兴证券股份有限公司 关于江西阳光乳业股份有限公司 2024 年度定期现场检查报告 | 保荐人名称：东兴证券股份有限公司 被保荐公司简称：阳光乳业 | | | --- | --- | | 保荐代表人姓名：张树敏 联系电话：010-66555305 | | | 保荐代表人姓名：周滨 联系电话：010-66555305 | | | 现场检查人员姓名：张树敏、周滨 | | | 现场检查对应期间：2023年12月1日-2024年12月31日 | | | 现场检查时间：2024年10月27日-2024年10月30日、2025年4月14日-2025年4月16日 | | | 一、现场检查事项 现场检查意见 | | | 不 （一）公司治理 是 适 | 否 | | 用 | | | 现场检查手段：查阅公司章程和公司治理相关制度；查阅三会文件及相关决议，核查其执行情 | | | 况；核查董监高人员变动及相关决策文件，以及信息披露文件；核查控股股东、实际控制人对 | | | 外投资情况；走访公司主要经营场所；与公司部分董事、高级管理人及实际控制人进行访谈。 | | | 1.公司章程和公司治理制度是否完备、合规 √ | | | 2.公 ...